Neither thioridazine nor gefitinib suppressed levels of activated Akt and p70S6K in NSCLC, but their combination reduced phospho-Akt and phospho-p70S6K levels in these cells (Fig. 4D). Here, RPS6KB1 is linked to non-small cell lung carcinoma.